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Summary Transfection of murine metastatic B78H1 cells (derived from B16 melanoma) with a syngeneic
H-2Kb gene was used to study the effect of Major Histocompatibility Complex (MHC) gene products on
tumour cell adhesion to endothelial cells and matrix proteins and the involvement in the metastatic process.
H-2Kb-expressing transfectants showed a reduced adhesion to endothelial surfaces of different origin (four
murine endotheliomas and human umbilical vein endothelial cells) when compared to parental B78H1 cells
and to controls transfected with pSV2neo alone. On the average a 50-70% reduction in adhesion to
endothelial cells was observed among H-2Kb transfectants. H-2Kb transfectants had a reduced expression of
the o4 integrin subunit, moreover the adhesion of Neo-transfected clones to endothelial cells was reduced to
the levels of H-2Kb transfectants by antibodies directed against the P, subunit and the endothelial VCAM-1
molecule, thus suggesting an impairment of the VLA-4/VCAM-1 interaction in H-2Kb transfectants. Adhesion
to extracellular matrix components was also strongly decreased: in general the adhesion of H-2Kb cells showed
a 50-75% inhibition with respect to Neo or parental controls. The highest difference was observed in
adhesion to vitronectin and laminin, the lowest in adhesion to fibronectin. Reduction in adhesive properties of
H-2Kb-expressing transfectants could be involved in the reduced metastatic ability, evaluated by means of
intravenous injection of cells: H-2Kb transfectants yielded less than ten lung colonies, while all controls
produced more than 100. Our data indicate that expression of a single class I MHC gene can significantly alter
the metastatic phenotype of MHC-negative tumour cells and this could be related to a general alteration of
tumour cell adhesive interactions.
The malignancy of tumour cells can be affected by alterations
of major histocompatibility complex (MHC) class I glyco-
protein expression (Wallich et al., 1985; Tanaka et al., 1988;
Elliott et al., 1989; Gopas et al., 1989). In particular it is
known that T lymphocytes do not interact with MHC-
negative cells (Doherty et al., 1984) and it has been
hypothesised that natural killer cells selectively recognise
MHC-negative cells (Llunggren & Karre, 1990).
It has been suggested that MHC molecules might play a
role also in phenomena not mediated by the immune system,
such as cell proliferation (Gattoni-Celli et al., 1989; Sunday
et al., 1989) and cell-cell interactions (Haliotis et al., 1990).
We have previously observed that H-2 negative cells trans-
fected with a syngeneic H-2Kb gene showed a greatly reduced
metastatic ability in mice. This effect was not fully explained
by immune-mediated properties of transfectants; other causes
might contribute to the strong decrease in metastatic ability,
as shown by the correlation with a reduced homotypic
adhesion (De Giovanni et al., 1991).
Tumour cell adhesion to extracellular matrix and to
endothelial cells appears to be an important step in meta-
stasis formation. A correlation between metastatic ability in
vivo and adhesive behaviour in vitro of tumour cells has been
reported by different groups (Nicolson, 1982; Varani et al.,
1985; Korach et al., 1986; Auerbach et al., 1987; Humphries
et al., 1988; Belloni & Tressler, 1989; Giavazzi et al., 1990).
Therefore in the present study we investigated whether trans-
fection of a MHC gene could lead to alterations in adhesive
ability of tumour cells to vascular endothelium and subendo-
thelial components.
To study the effect of MHC gene products on tumour cell
adhesion and the relation with metastatic ability, we used
H-2Kb_positive transfectants and control clones (transfected
with pSV2neo gene only) obtained from a murine melanoma
clone (derived from B16 cell line) showing no class I H-2b
expression (De Giovanni et al., 1991).
Materials and methods
Tumour cells
B78H1 is an amelanotic clone originally obtained in the
laboratory of S. Silagi from B16 melanoma (Graf et al.,
1984); it shows no H-2 expression even after interferon-'y
treatment. The derivation of control (transfected with
pSV2neo gene encoding resistance to the neomycin analogue
G418) and H-2Kb transfectants has been described previously
(De Giovanni et al., 1991).
In the present study, H-2-negative B78H1 and four control
clones were compared to five H-2Kb transfectants, one of
which (Kb-G56) showed a poor, even though interferon-
inducible, H-2Kb expression.
Cells were cultured in Dulbecco's modified Eagle medium
(DMEM) supplemented with 10% heat-inactivated foetal calf
serum (FCS) and 500ILgml-' G418 (except for parental
B78H1) and were maintained at 37°C in a humidified atmo-
sphere of 5% CO2 in air. All the cells used in the experiments
reported here were >90% viable as judged by Trypan blue
dye exclusion.
Immunofluorescence studies
Indirect immunofluorescence on cells suspended by trypsin-
EDTA treatment (for H-2 expression) or 5 mM EGTA in
Ca2+/Mg2+-free PBS (for integrin expression) was performed
as described (De Giovanni et al., 1991) and subjected to flow
cytometric analysis (FACSstar plus, Becton Dickinson,
Mountain View, CA, USA). Results from individual experi-
ments are shown but these are representative of at least three
similar individual experiments.
H-2b expression was determined by means of monoclonal
antibody H-142-23 (anti-H-2Kb), obtained from Serotec,
Bicester, UK; FITC-conjugated goat Fab anti-mouse
immunoglobulins were purchased from Technogenetics,
Milano, Italy.
Goat serum to human a5pl fibronectin receptor (which
recognises the PI integrin subfamily) was prepared in our
laboratory (Conforti et al., 1989). FITC-conjugated mouse
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(F(ab)'2 anti-goat IgG was purchased from New England
Corporation, Boston, Mass., USA.
Expression of aC4 integrin subunit was determined by means
of anti-mouse L-PAM-1 rat monoclonal antibody (Phar-
mingen, San Diego, CA, USA) and FITC-conjugated rabbit
anti-rat immunoglobulins (Dakopatts, Glostrup, Denmark).
Endothelial cells
The murine endothelial cell lines used in this study were
obtained through the courtesy of Dr E.F. Wagner (IMP,
Wien, Austria) (Williams et al., 1988; Williams et al., 1989).
These endothelioma cell lines, originally derived from a sub-
cutaneous (sEnd.1), thymic (tEnd.1), embryonal (eEnd.1) and
brain (bEnd.4) hemangioma, express the polyoma middle T
antigen, have cobblestone-like morphology, express von
Willebrand factor and cause hemangiomas in vivo. Cells were
maintained in DMEM containing 15% FCS and 750 .tg ml-'
G418.
Human endothelial cells (HEC), obtained from human
umbilical vein and cultured as previously described (Dejana
et al., 1987), were routinely characterised by immunofluores-
cence techniques using rabbit anti-human factor VIII antigen
(Behringwerke, AG, Marburg, Germany) (Balconi & Dejana,
1986; Dejana et al., 1989). The cells were cultured in medium
199 (M199) supplemented with 20% FCS, 50 jig ml-'
endothelial cell growth supplement (prepaed from bovine
brain), 100 tg ml-' heparin (Sigma Chemical Co., St. Louis,
MO, USA), 50 U ml-1 penicillin, 50 tg ml-' streptomycin,
2.5 tLg ml-' fungizone at 37°C. All culture reagents were pur-
chased from Gibco Europe, Paisley, Scotland. Tissue culture
plates and flasks were obtained from Falcon (Becton Dickin-
son, Plymouth, UK).
Adhesion assay
Murine endothelial cell lines grown to confluent monolayers
in 96 well plates were washed twice with fresh DMEM
containing 15% FCS. The same procedure was utilised in the
experiments on HEC using M199 plus 20% FCS. In these
experiments HEC were also activated with 20 U ml-' of
human recombinant interleukin-i,I (specific activity
I0 UfLg-'; Sclavo, Siena, Italy).
In other experiments, tumour cell adhesion to endothelial
cell matrix or to extracellular matrix proteins (fibronectin,
vitronectin and laminin) was studied. Subendothelial matrix
was exposed by washing endothelial cell monolayers with
PBS without Ca2+/Mg2+ and subsequent incubation with
5 mM EGTA in PBS without Ca2+/Mg2+ for 10 min. Endo-
thelial cell detachment was assessed by light microscopy. The
exposed matrix was then washed twice with PBS before
adhesion. Fibronectin, vitronectin and laminin were prepared
and used for coating the adhesion plate wells at 4°C over-
night as described (Lampugnani et al., 1991).
Tumour cells were radiolabelled for 18 h with 125lodode-
oxyuridine (Amersham International, Amersham, UK)
(1 ,uCi ml-') and then washed twice with PBS without Ca2+/
Mg2+ before detachment by incubation for 15 min with 5 mM
EGTA in PBS without Ca2+/Mg2+. Cells were washed twice
with DMEM plus 10% FCS and finally resuspended at
4 x 105 cells ml-' either in M199 plus 20% FCS (adhesion on
HEC) or in DMEM plus 15% FCS (when utilised for ad-
hesion on murine endothelial cell lines).
Radiolabelled tumour cells suspension (100 tl of
4 x 105 ml-) was added to each well and then incubated for
30min at 37°C. Non-adherent cells were then removed by
washing the plates three times with PBS plus 2% FCS. The
content of each well was solubilised with 100 1l of 1 M
NaOH-1% SDS and the lysate counted in a gamma 5500
counter (Beckman, Fullerton, California, USA).
In some experiments, adhesion assay was performed also
in the presence of the following neutralising antibodies. Anti-
ICAM-1 mAb 6.5BS (Wellicome et al., 1990), obtained
through the courtesy of Dr Haskard (Hammersmith Hospital,
London); the antibody, in the form of supernatant, was used
at 1:20 dilution. Anti-VCAM-l (B) 4B9 was a nice gift of Dr
Harlan (Carlos et al., 1990); the antibody in the form of
purified IgG was used at lOtLgmlm'. Anti-Pl goat antiserum,
described above, has been used at 1:100 dilution. These
concentrations of the antibodies have been selected since they
gave maximal inhibition in the appropriate assays as specified
in the respective references.
Mice and in vivo treatments
C57BL/6AnNCrlBR (referred to as C57BL/6) male mice
were purchased from Charles River, Calco, Italy. Experi-
mental lung metastases were counted 28 days after the in-
travenous (i.v.) injections of 5 x 105 B78H1 or transfectant
cells. suspended in PBS into a lateral tail vein of 8-12
week-old mice. Lung nodules produced by amelanotic cells
were contrasted with black India ink as described (Wexler,
1966). All metastasis counts were performed on dissected
lung lobes under a stereoscopic microscope.
Statistical analysis
Statistical analysis was performed by Student's t-test (cell
adhesion experiments) and by the non-parametric Wilcoxon
test (experimental metastasis study).
Results
A greatly reduced metastatic ability of H-2Kb transfected
cells has been reported in a previous paper (De Giovanni et
al., 1991), where some of the clones hereafter studied were
characterized. For the present study, a wider panel of H-2Kb
transfectants (referred to as 'Kb' clones) and control clones
(transfected with pSVneo alone, 'Neo' clones) has been used.
H-2Kb expression (Figure 1) and metastatic ability (Table I)
of all the clones used throughout the study is reported for
comparison. Four H-2Kb-expressing transfectants and a Kb
clone (Kb-G56) with a poor basal H-2Kb expression (Figure
1) were compared to H-2Kb-negative parental B78H1 cells
and to four control 'Neo' clones. The experimental metastatic
capacity of Kb clones was strikingly reduced in comparison
to Neo controls as reported (Table I).
We examined adhesion of parental, Neo and H-2Kb trans-
fected melanoma clones to murine endothelial cells (bEnd).
As shown in Figure 2, adhesion to bEnd cells of all the
H-2Kb-expressing clones was significantly lower than parental
and Neo clones; Kb-G56 showed an intermediate behaviour.
This adhesive pattern is in accordance with the decreased
experimental metastatic ability of H-2Kb-expressing transfec-
tants (Table I). The fact that Kb-G56 was significantly more
adhesive and more metastatic than H-2Kb-expressing trans-
fectants confirms that H-2 expression, rather than gene trans-
fection per se, determined the inhibition of adhesion and of
metastatic ability.
Similarly to the results observed on bEnd, we found a
significantly decreased adhesion of the H-2Kb transfected
Table I Comparison of metastatic ability in vivo of Neo and
H-2Kb_transfected clones
Lung colonies
Clone H-2Kb Incidence Median Range
B78H1 - 6/6 >200 >200
Neo-CIA - 8/8 156 55->200
Neo-ClC - 8/8 146 52->200
Neo-C23 - 8/8 118 70-165
Neo-C29 - 7/7 129 65-> 200
Kb-G56 + 8/8 44 12- 123
Kb-DIA + 4/8 1 0-6
Kb-D34 + 7/8 3 0-8
Kb-G62 + 7/7 6 1 -15
Kb-G60 + 3/8 0 0-2864 D. LAURI et al.
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Figure 2 Adhesion of parental, Neo and H-2Kb-transfected (Kb)
melanoma clones to brain derived murine endothelial cells.
Results are expressed as tumour cell number/well, mean + s.d., 18
replicates from three experiments.
cells to other murine endothelial cell lines of subcutaneous
(sEnd) and thymic (tEnd) origin (Figure 3) compared to
parental and Neo clones. Adhesion to the embryo-derived
eEnd cell line was very low, and no significant difference was
observed.
We also tested adhesion to human umbilical vein endo-
thelial cells (HEC), under resting condition and after
cytokine activation. Tumour cell adhesion to HEC, similarly
to leukocyte adhesion, is significantly increased by treatment
of the endothelium with inflammatory cytokines as inter-
leukin-1 (IL-1) and tumour necrosis factor (Dejana et al.,
1988; Rice et al., 1989; Lauri et al., 1990; Martin-Padura et
al., 1991). Adhesion of parental, control and Kb clones to
resting and IL-1-activated HEC is shown in Figure 4. Con-
sistently with the results obtained using murine endothelial
cells, B78H1 and Neo-C23 adhesion to resting HEC is higher
than Kb-D34 cells. Adhesion to IL-1-activated HEC of
B78H1 and Neo-C23 clones was significantly increased, as
expected; on the contrary Kb-D34 cells did not enhance their
adhesion after endothelial activation.
Adhesive interaction between melanoma and endothelial
cells could be mediated by the binding of VLA-4 integrin
receptor to the endothelial VCAM-1 counterpart. When cells
were studied by cytofluorimetric analysis, control Neo cells
were found to express OE4 subunit, although at a low level,
whereas Kb-transfectant cells were almost x4-negative (Table
II). This difference could not be attributed to a smaller
dimension of Kb cells (Table II) or to a generalised decrease
in the expression of adhesion molecules, since Kb and Neo
10000 20 000
Cell numnber/well
Figure 3 Adhesion of three melanoma clones to embryonal
(eEnd), subcutaneous (sEnd), and thymic (tEnd) derived murine
endothelial cells. B78H1 = open bars, Neo-C23 = shaded bars,
Kb-D34= solid bars. Results are expressed as tumour cell
number/well, mean ± s.d., 18 replicates from three experiments.
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Table II Expression of 0(4 and CD44 by Neo and H-2K -transfected
clones
Cell diameter
H-2Kh (pim)
- 14.7
- 15.2
- 13.4
- 13.4
Neo clones, mean ± s.c.
C4 CD44
16 32
10 24
13 25
16 21
14.2 + 0.5 13.8 ± 1.4 25.5 ± 2.3
Kb-DIA
Kb-D34
Kb-G62
Kb-G60
+ 13.9
+ 14.3
+ 15.2
+ 15.4
Kb clones, Mean + s.e.
Difference between Neo
and Kb
6
5
2
4
22
28
33
14
)o iooo 15
Cell number/well
14.7 + 0.4 4.3 ± 0.9 24.3 ± 4.1 Figure 5 Effect of neutralising antibodies on the adhesion of
n.s. P<0.01 n.s.
resting (open bars)
~~~(solid bars).
Integrin aC4 subunit and CD44 expression were measured by flow
cytometry; results are expressed as median log fluorescence channel
in arbitrary units. Cell diameter was measured microscopically.
Student's t-test was used to compare Neo and Kb clones.
clones expressed equal amounts of CD44 (Table II) and of
the integrin subunit (data not shown).
Adhesion assay was performed also in the presence of
neutralising antibodies (Figure 5): both anti-VCAM-1 and
anti-136 subunit significantly inhibited ahdesion of Neo-C23
cells. The adhesion of Neo-C23 cells to endothelial cells was
reduced by these neutralising antibodies to levels similar to
H-2Kb transfectants, thus confirming the role played by the
VLA-4/VCAM-1 interaction.
We then tested whether adhesion impairment of H-2Kb
B78H1
Neo-C23_
Kb-D34 I-Cnto
0 10 000 20 000 30 000
Cell number/well
Figure 4 Adhesion of parental (B78HI), control (Neo-C23) and
Kb-transfected (Kb-D34) clones to resting (open bars) and IL-1-
activated HEC (solid bars). Results are expressed as tumour cell
number well, mean ± s.d.. 18 replicates from three experiments.
transfected cells was specific to endothelial cells or common
to other adhesive substrata. Therefore we compared adhesion
to endothelial cell matrix and to purified extracellular matrix
proteins such as fibronectin, vitronectin and laminin. Table
III shows that H-2Kb transfected cells have a significant
decrease in adhesiveness to all the substrata tested compared
to B78HI and Neo-C23 cells.
Finally to verify if the adhesive behaviour of H-2Kb trans-
fected cells was due to an abnormal cytoskeletal organisation
we compared, by phalloidin-rhodamine staining of para-
formaldehyde-fixed cell monolayers, the actin filament distri-
bution of Neo-C23 and Kb-D34 cells. No significant
difference was observed (data not shown): actin micro-
filament organisation and cell spreading were comparable in
the two cell types.
Discussion
Our data show that transfection of the H-2Kb gene altered
adhesion of tumour cells to different endothelial surfaces
(namely three murine endothelial cell lines and HEC).
Adhesion of H-2Kb transfectants to extracellular matrix com-
ponents was also strongly decreased in respect to control
clones.
MHC class I glycoprotein expression is required for recog-
nition of tumour cells by the immune system of the host
(Doherty et al., 1984). Moreover MHC gene products can be
involved in other functions potentially relevant to the meta-
static process, such as cell-cell interactions (Bartlett & Edidin,
1978; Curtis & Rooney, 1979; Schirrmacher et al., 1980;
Honda & Rostami, 1989), homotypic cell adhesion (De
Giovanni et al., 1991) and lectin-binding ability (Gorelik et
al., 1991). Our observations support the idea that H-2Kb
glycoprotein expression profoundly affects the adhesive
capacity of the cell, since a general decrease of tumour cell
adhesion to different adhesive substrata was observed.
Several lines of evidence show that tumour cell interaction
with extracellular matrix is relevant and related to the meta-
Table III Adhesion of H-2K' transfected and control melanoma cells to various
adhesive substrates
Substrate of' cilies.ion
Tutmouir ce/Is EC matrix FN VN LM
B78H1 5138 ± 475 6082 ± 350 6052 + 339 5726 ± 278
26% 31% 30% 29'S
Neo-C23 3665 + 619 5923 ± 278 5318 ± 714 5334 + 92
18% 30% 27% 27'
Kb-D34 710 ± 396 3908 + 702 1278 + 510 1428 + 168
4% 190% 6% 7%
Results are expressed as number of adherent tumour cells well, mean + s.d.,
eight replicates from two experiments. In % is expressed the percentage of
adherent cells respect to the total number of cells added/well. Adhesion time was
30 min. FN = fibronectin, VN = vitronectin, LM = laminin.
Clone
Neo-CIA
Neo-CIC
Neo-C23
Neo-C29
ICAM-
VCAM-
0
,0
c: NorIE
ICAM-1
VCAM-1866 D. LAURI et al.
stasis formation in vivo (McCarthy et al., 1985; Nicolson,
1988; Ruoslahti & Giancotti, 1989; Albelda et al., 1990). It
has been shown that small RGD peptides, that can block by
competition tumour cell integrin receptors for extracellular
matrix (Hynes, 1987), are able to reduce metastasis formation
in vivo (Humphries et al., 1988; Saiki et al., 1989).
Tumour cell adhesion to endothelial cells is also important
for the metastatic process. Some authors found a positive
correlation between cell adhesion to endothelial cells or to
subendothelial matrix proteins and metastatic potential of
tumour cell lines (Belloni & Tressler, 1989) and in particular
of melanoma cells (including B16) (Chang et al., 1992;
Kojima et al., 1992; Zhu et al., 1992). In these papers,
inhibition of both adhesion and metastasis was achieved by
specific antibodies blocking different adhesion molecules.
Here we showed that H-2Kb gene transfection in H-2-nega-
tive melanoma cells leads to both a decreased adhesion to
endothelial cells and matrix proteins and to a dramatic
reduction in the metastatic ability.
It has been previously reported that melanoma cells adhere
more efficiently to IL-l-treated endothelium (Rice & Bevi-
lacqua, 1989; Martin-Padura et al., 1991). This phenomenon
was related to an increase in the number and incidence of
artificial and spontaneous metastasis in IL-1-treated animals
injected with melanoma cell lines (Giavazzi et al., 1990). We
reported here that, in contrast to the parental line and Neo
clones, IL-1 treatment of the endothelium did not change the
ability of H-2Kb transfectants to adhere to it.
The augmentation of melanoma adhesiveness to cytokine-
treated HEC has been proven to be mediated by the recogni-
tion of the endothelial adhesive membrane protein VCAM-1
by melanoma counter receptor VLA-4 (Rice & Bevilacqua,
1989; Martin-Padura et al., 1991). Since M4 expression was
indeed depressed in H-2Kb transfectants, it is likely that
H-2Kb transfection impairs VLA-4/VCAM-1 typical recogni-
tion.
The mechanism underlying the profound depression of
adhesion both to the endothelium and matrix proteins
observed in H-2Kb transfectants cannot however be com-
pletely explained by an inhibition of a4I1 expression. This
integrin can bind fibronectin but there is no evidence that it
can interact with laminin and vitronectin. Furthermore
VCAM-1 is expressed on resting endothelium only in mini-
mal amounts (Rice et al., 1990). This suggests that also other
mechanisms play a role in H-2Kb_induced decrease of
adhesive functions. Actin cytoskeletal organisation was not
important since H-2Kb transfectants showed a normal
microfilament pattern and spreading. A possibility could be
that H-2 glycoproteins sterically hinder cell adhesion
molecules required for melanoma adhesion to endothelial
cells and to extracellular matrix. We are currently expanding
the panel of available reagents recognising murine adhesion
molecules, to obtain a comprehensive evaluation of the
differences between Neo and Kb cells.
In conclusion our data indicate that expression of a single
class I MHC gene can significantly alter tumour cell adhesive
interactions. This alteration, along with the reported
interference with the immune system of the hosts, could
contribute to determine the decreased metastatic ability.
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